Home Medicine Effect of integrated Yoga and Physical therapy on audiovisual reaction time, anxiety and depression in patients with chronic multiple sclerosis: a pilot study
Article
Licensed
Unlicensed Requires Authentication

Effect of integrated Yoga and Physical therapy on audiovisual reaction time, anxiety and depression in patients with chronic multiple sclerosis: a pilot study

  • Shivaji Chobe EMAIL logo , Hemant Bhargav , Nagarathna Raghuram and Christoph Garner
Published/Copyright: June 23, 2016

Abstract

Background: Multiple sclerosis (MS) is characterized by a significant deterioration in auditory and visual reaction times along with associated depression and anxiety. Yoga and Physical therapy (PT) interventions have been found to enhance recovery from these problems in various neuropsychiatric illnesses, but sufficient evidence is lacking in chronic MS population. The aim of this study was to assess the effect of integrated Yoga and Physical therapy (IYP) on audiovisual reaction times, depression and anxiety in patients suffering from chronic MS.

Methods: From a neuro-rehabilitation center in Germany, 11 patients (six females) suffering from MS for 19±7.4 years were recruited. Subjects were in the age range of 55.45±10.02 years and had Extended Disability Status Scores (EDSS) below 7. All the subjects received mind–body intervention of integrated Yoga and Physical therapy (IYP) for 3 weeks. The intervention was given in a residential setup. Patients followed a routine involving Yogic physical postures, pranayama, and meditations along with various Physical therapy (PT) techniques for 21 days, 5 days a week, 5 h/day. They were assessed before and after intervention for changes in audiovisual reaction times (using Brain Fit Model No. OT 400), anxiety, and depression [using Hospital Anxiety and Depression Scale (HADS)]. Data was analyzed using paired samples test.

Results: There was significant improvement in visual reaction time (p=0.01), depression (p=0.04), and anxiety (p=0.02) scores at the end of 3 weeks as compared to the baseline. Auditory reaction time showed reduction with borderline statistical significance (p=0.058).

Conclusions: This pilot project suggests utility of IYP intervention for improving audiovisual reaction times and psychological health in chronic MS patients. In future, randomized controlled trials with larger sample size should be performed to confirm these findings.

Acknowledgments

The authors are thankful to the subjects who participated in the study.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: Authors are thankful to KWA Klinik Stift Rottal Bad Griesbach, Germany, for their support for conducting this study.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Buelow JM. A correlational study of disabilities, stressors and coping methods in victichronic MS of multiple sclerosis. J Neurosci Nurs 1991;23:247–2.10.1097/01376517-199108000-00012Search in Google Scholar PubMed

2. Counte MA, Bieliauskas LA, Pavlou M. Stress and personal attitudes in chronic illness. Arch Phys Med Rehabil 1983;64:272–5.Search in Google Scholar

3. Chalk HM. Mind over matter: cognitive-behavioral determinants of emotional distress in multiple sclerosis patients. Psychol Health Med 2007;12:556–6.10.1080/13548500701244965Search in Google Scholar PubMed

4. Valadbeigi A, Weisi F, Rohbakhsh N, Rezaei M, Heidari A, Rasa AR. Central auditory processing and word discrimination in patients with multiple sclerosis. Eur Arch Otorhinolaryngol 2014;271:2891–6.10.1007/s00405-013-2776-6Search in Google Scholar PubMed PubMed Central

5. Matas CG, Matas SL, Oliveira CR, GonçalvesI C. Auditory evoked potentials and multiple sclerosis. Arq Neuropsiquiatr 2010;68:528–34.10.1590/S0004-282X2010000400010Search in Google Scholar PubMed

6. Gundogan FC, Tas A, Altun S, Oz O, Erdem U, Sobaci G. Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis. Indian J Ophthalmol 2013;61:100–3.10.4103/0301-4738.99842Search in Google Scholar PubMed PubMed Central

7. Saxena R, Bandyopadhyay G, Singh D, Singh S, Sharma P, Menon V. Evaluation of changes in retinal nerve fiber layer thickness and visual functions in cases of optic neuritis and multiple sclerosis Indian J Ophthalmol 2013;61:562–6.10.4103/0301-4738.121071Search in Google Scholar PubMed PubMed Central

8. Chard D, Miller D. Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging. J Neurol Sci 2009;282:5–11.10.1016/j.jns.2009.01.012Search in Google Scholar PubMed

9. Shiee N, Bazin PL, Ozturk A, Reich DS, Calabresi PA, Pham DL. A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions. NeuroImage 2010;49:1524–5.10.1016/j.neuroimage.2009.09.005Search in Google Scholar PubMed PubMed Central

10. Pitt D, Boster A, Pei W, Wohleb E, Jasne A, Zachariah CR, et al. Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging. Arch Neurol 2010;67:812–18.10.1001/archneurol.2010.148Search in Google Scholar PubMed

11. Schwarz S, Knorr C, Geiger H, Flachenecker P. Complementary and alternative medicine for multiple sclerosis. Mult Scler 2008 Epub;14(8):1113–19.10.1177/1352458508092808Search in Google Scholar PubMed

12. Liu XJ, Ye HX, Li WP, Dai R, Chen D, Jin M. Relationship between psychosocial factors and onset of multiple sclerosis. Eur Neurol 2009;62:130–6.10.1159/000226428Search in Google Scholar

13. Warren S, Warren KG. Prevalence, incidence, and characteristics of multiple sclerosis in Westlock County, Alberta, Canada. Neurology 1993;43:1760–3.10.1212/WNL.43.9.1760Search in Google Scholar

14. Ackerman KD, Heyman R, Rabin BS, Anderson BP, Houck PR, Frank E, et al. Stressful life events precede exacerbations of multiple sclerosis. Psychosom Med 2002;64:916–20.10.1097/00006842-200211000-00009Search in Google Scholar

15. Mohr DC, Hart SL, Julian L, Cox D, Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 2004;328:731.10.1136/bmj.38041.724421.55Search in Google Scholar

16. Mohr DC, Hart SL, Julian L, Cox D, Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 2004;3287442:731.10.1136/bmj.38041.724421.55Search in Google Scholar

17. Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 2007;13:67–72.10.1177/1352458506071161Search in Google Scholar

18. Minden SL, Orav J, Reich P. Depression in multiple sclerosis. Gen Hosp Psychiatr 1987;9:426–34.10.1016/0163-8343(87)90052-1Search in Google Scholar

19. Schubert DS, Foliart RH. Increased depression in multiple sclerosis patients: a meta-analysis. Psychosomatics 1993;34:124–30.10.1016/S0033-3182(93)71902-7Search in Google Scholar

20. Patten SB, Beck CA, Williams JV, Barbui C, Metz LM. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003;61:1524–7.10.1212/01.WNL.0000095964.34294.B4Search in Google Scholar PubMed

21. Büssing A, Michalsen A, Khalsa SB, Telles S, Sherman KJ. Effects of yoga on mental and physical health: a short summary of reviews. Evid Based Complement Altern Med 2012;2012:165410.10.1155/2012/165410Search in Google Scholar PubMed PubMed Central

22. Senders A, Wahbeh H, Spain R, Shinto L. Mind-body medicine for multiple sclerosis: a systematic review. Autoimmune Dis 2012;2012:567324.10.1155/2012/567324Search in Google Scholar PubMed PubMed Central

23. Cramer H, Lauche R, Langhorst J, Dobos G. Yoga for depression: a systematic review and meta-analysis. Depress Anxiety 2013;30:1068–83.10.1002/da.22166Search in Google Scholar

24. Skowronek IB, Mounsey A, Handler L. Clinical Inquiry: can yoga reduce symptochronic MS of anxiety and depression? J Fam Pract 2014;63:398–407.Search in Google Scholar

25. Saeed SY, Diana JA, Richard MB. Exercise, yoga, and meditation for depressive and anxiety disorders. Am Fam Physician 2010;81:981–6.Search in Google Scholar

26. Rajan AI, Dixit RK, Joshi AR. Effect of yoga on aerobic power, anaerobic power and audio-visual reaction time in healthy individuals. Int J Physiol 2014;2(1):9.10.5958/j.2320-608X.2.1.003Search in Google Scholar

27. Jore SB, Kamble P, Bhutada TB, Patwardhan MS. Effect of Pranayama training on audio-visual reaction time. Int J Healthcare Biomed Res 2013;2(1):35–7.Search in Google Scholar

28. Bhavanani AB, Madan M, Udupa K. Acute effect of Mukh bhastrika (a yogic bellows type breathing) on reaction time. Indian J Physiol Pharmacol 2003;47:297–300.Search in Google Scholar

29. Telles S, Nagarathna S, Nagendra HR, Desiraju T. Alterations in auditory middle latency evoked potentials during meditation on a meaningful symbol Om. Intern J Neurosci 1994;76:87–93.10.3109/00207459408985995Search in Google Scholar

30. Telle S, Joseph C, Venkatesh S, Desiraju T. Alterations of auditory middles latency evoked potentials during yogic consciously regulated breathing and attentive state of mind. Int J Psychophysiol 1993;14:189–98.10.1016/0167-8760(93)90033-LSearch in Google Scholar

31. Telle S, Dash M, Manjunath NK, Deginal R, Naveen KV. Effect of Yoga on visual perception and visual strain. J Mod Opt 2007;54:1379–83.10.1080/09500340600855593Search in Google Scholar

32. Manjunath NK, Telles S. Improvement in visual perceptual sensitivity in children following yoga training. J Indian Psychol 1999;17:41–5.Search in Google Scholar

33. Borker AS, Pednekar JR. Effect of Pranayam on visual and auditory reaction time. Indian J Physiol Pharmacol 2003;47:229–30.Search in Google Scholar

34. Madan M, Thombre DP, Balakumar B, Nambinarayanan TK, Thakur S, Krishnamurthy N, et al. Effect of yoga training on reaction time, respiratory endurance and muscle strength. Indian J Physiol Pharmacol 1992;36:229–33.Search in Google Scholar

35. Sharma VK, Kumar MR, Velkumary S, Subramanian SK, Bhavanani AB, Madan M, et al. Effect of fast and slow pranayama practice on cognitive functions in healthy volunteers. J Clin Diagn Res 2014;8:10–13.Search in Google Scholar

36. Hariprasad VR, Koparde V, Sivakumar PT, Varambally S, Thirthalli J, Varghese M, et al. Randomized clinical trial of yoga-based intervention in residents from elderly homes: Effects on cognitive function. Indian J Psychiatr 2013;55(Suppl):S357–63.10.4103/0019-5545.116308Search in Google Scholar PubMed PubMed Central

37. Monroe R, Nagarathana R, Nagendra HR. Yoga for common ailments. Bangalore: Swami Vivekananda Yoga Prakashan 2010.Search in Google Scholar

38. Nesi E.Yoga and meditation: helpful techniques to improve the life of cancer patients. G Ital Med Lav Ergon 2011;34(2 Suppl B):B7–11.Search in Google Scholar

39. Ahmadi A, Arastoo AA, Nikbakht M, Zahednejad S, Rajabpour M. Comparison of the effect of 8 weeks aerobic and Yoga training on ambulatory function, fatigue and mood status in chronic MS patients. Iran Red Crescent Med J 2013;15:449–54.10.5812/ircmj.3597Search in Google Scholar PubMed PubMed Central

40. Oken BS, Kishiyama S, Zajdel D, Bourdette D, Carlsen J, Haas M, et al. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 2004;62:2058–64.10.1212/01.WNL.0000129534.88602.5CSearch in Google Scholar PubMed

41. Patil NJ, Nagaratna R, Garner C, Raghuram NV, Crisan R. Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis – a prospective observational case series. Complement Ther Med 2012;20:424–30.10.1016/j.ctim.2012.08.003Search in Google Scholar PubMed

42. Salgado BC, Jones M, Ilgun S, McCord G, Loper-Powers M, Houten P. Effects of a 4-month Ananda Yoga Program on physical and mental health outcomes for persons with multiple sclerosis. Int J Yoga Therap 2013;23:27–38.10.17761/ijyt.23.2.201k61q276486622Search in Google Scholar

43. Oken BS, Flegal K, Zajdel D, Kishiyama SS, Lovera J, Bagert B, et al. Cognition and fatigue in multiple sclerosis: potential effects of medications with central nervous system activity. J Rehabil Res Dev 2006;43:83–90.10.1682/JRRD.2004.11.0148Search in Google Scholar

44. Grossman P, Kappos L, Gensicke H, D’Souza M, Mohr DC, Penner IK, et al. chronic MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology 2010;75:1141–9.10.1212/WNL.0b013e3181f4d80dSearch in Google Scholar

45. Senders A, Wahbeh H, Spain R, Shinto L. Mind-body medicine for multiple sclerosis: a systematic review. Autoimmune Dis 2012;2012:567324.10.1155/2012/567324Search in Google Scholar

46. Doulatabad SN, Nooreyan K, Doulatabad AN, Noubandegani ZM. The effects of pranayama, hatha and raja yoga on physical pain and the quality of life of women with multiple sclerosis. Afr J Tradit Complement Altern Med 2012;10:49–52.10.4314/ajtcam.v10i1.8Search in Google Scholar

47. Wiles CM, Newcombe RG, Fuller KJ, Shaw S, Furnival-Doran J, Pickersgill TP, et al. Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:174–9.10.1136/jnnp.70.2.174Search in Google Scholar

48. Snook EM, Motl RW. Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis. Neurorehabil Neural Repair 2009;23:108–16.10.1177/1545968308320641Search in Google Scholar

49. Solari A, Filippini G, Gasco P, Colla L, Salmaggi A, La Mantia L, et al. Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurology 1999;52:57.10.1212/WNL.52.1.57Search in Google Scholar

50. Kesselring J, Beer S. Symptomatic therapy and neurorehabilitation in multiple sclerosis. Lancet Neurol 2005;4:643–52.10.1016/S1474-4422(05)70193-9Search in Google Scholar

51. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121–7.10.1002/ana.1032Search in Google Scholar PubMed

52. Raghuraj P, Ramakrishnan AG, Nagendra HR, Telles S. Effect of two selected yogic breathing techniques on heart rate variability. Indian J Physiol Pharmacol 1998;42:467–72.Search in Google Scholar

53. Raghuraj P, Telles S. Immediate effect of specific nostril manipulating yoga breathing practices on autonomic and respiratory variables. Appl Psychophysiol Biofeedback 2008;33:65–75.10.1007/s10484-008-9055-0Search in Google Scholar PubMed

54. Kalyani BG, Venkatasubramanian G, Arasappa R, Rao NP, Kalmady SV, Behere RV, et al. Neurohemodynamic correlates of ‘OM’ chanting: a pilot functional magnetic resonance imaging study. International journal of yoga 2011;4(1):3.10.4103/0973-6131.78171Search in Google Scholar PubMed PubMed Central

55. Mason RR, Cochrane DJ, Denny GJ, Firth EC, Stannard SR. Is 8 weeks of side-alternating whole-body vibration a safe and acceptable modality to improve functional performance in multiple sclerosis? Disabil Rehabil 2012;34:647–54.10.3109/09638288.2011.615370Search in Google Scholar PubMed

56. Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G. Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev 2005;1:CD003980.10.1002/14651858.CD003980Search in Google Scholar

57. Ferruh T, Ummuhan BA, Nuran S, Ugur C. Implementation of matrix rhythm therapy and conventional massage in young females and comparison of their acute effects on circulation. J Altern Complement Med 2013;19:826–32.10.1089/acm.2012.0932Search in Google Scholar PubMed PubMed Central

58. Audio-visual reaction time was measured using Device Brain-Fit Model No OT 4000. Available at: www.audiva.org/download/e_BFE_manual_lowres.pdf.Search in Google Scholar

59. Zigmond AS, Philip RS. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–70.10.1037/t03589-000Search in Google Scholar

60. Wiles CM, Newcombe RG, Fuller KJ, Shaw S, Furnival-Doran J, Pickersgill TP, et al. Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatr 2001;70:174–9.10.1136/jnnp.70.2.174Search in Google Scholar PubMed PubMed Central

61. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 1996;39:432–41.10.1002/ana.410390405Search in Google Scholar PubMed

62. Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G. Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev 2004;3;6-9.10.1002/14651858.CD003980Search in Google Scholar

63. Telles S, Nagarathna S, Nagendra HR, Desiraju T. Alterations in auditory middle latency evoked potentials during meditation on a meaningful symbol OM. Int J Neurosci 1994;76:87–93.10.3109/00207459408985995Search in Google Scholar PubMed

64. Telle S, Dash M, Manjunath NK, Deginal R, Naveen KV. Effect of Yoga on visual perception and visual strain. J Mod Opt 2007;54:1379–83.10.1080/09500340600855593Search in Google Scholar

65. Manjunath NK, Telles S. Improvement in visual perceptual sensitivity in children following Yoga training. J Indian Psychol 1999;17:41–5.Search in Google Scholar

66. Streeter CC, Whitfield TH, Owen L, Rein T, Karri SK, Yakhkind A, et al. Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study. J Altern Complement Med 2010;16:1145–52.10.1089/acm.2010.0007Search in Google Scholar PubMed PubMed Central

67. Streeter CC, Gerbar PL, Saper RB, Ciraulo DA, Brown RP. Effects of yoga on the autonomic nervous system, gamma-aminobutyric-acid, and allostasis in epilepsy, depression, and post-traumatic stress disorder. Med Hypotheses 2012;78:571–9.10.1016/j.mehy.2012.01.021Search in Google Scholar PubMed

68. Naveen GH, Thirthalli J, Rao MG, Varambally S, Christopher R, Gangadhar BN. Positive therapeutic and neurotropic effects of yoga in depression. A comparative study. Indian J Psychiatr 2013;55(Suppl):S400–4.10.4103/0019-5545.116313Search in Google Scholar PubMed PubMed Central

69. Ma Q. Beneficial effects of moderate voluntary physical exercise and its biological mechanisms on brain health. Neurosci Bull 2008;24:265–70.10.1007/s12264-008-0402-1Search in Google Scholar PubMed PubMed Central

Received: 2015-11-26
Accepted: 2016-5-1
Published Online: 2016-6-23
Published in Print: 2016-9-1

©2016 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. Hepatoprotective Ayurvedic plants – a review
  4. Opinion Paper
  5. Stinging plants: as future bio-weapon
  6. Preclinical Studies
  7. Phytochemical screening, safety evaluation, anti-inflammatory and analgesic studies of the leaf extracts of Sterculia tragacantha
  8. In vitro bactericidal activity of Berberis aristata extract against clinical isolates of carbapenem-resistant Escherichia coli
  9. Antioxidant and antimicrobial capacities of ethanolic extract of Pergularia daemia leaves: a possible substitute in diabetic management
  10. Influence of piperine and quercetin on antidiabetic potential of curcumin
  11. In vitro activity of Lycium barbarum (Goji) against major human phase I metabolism enzymes
  12. Development of an antidiabetic polyherbal formulation (ADPHF6) and assessment of its antioxidant activity against ROS-induced damage in pUC19 and human lymphocytes – an in vitro study
  13. Potentials of Mangifera indica in the treatment of depressive-anxiety disorders: possible mechanisms of action
  14. Semen characteristics and sperm morphology of Pistia stratiotes Linn. (Araceae) protected male albino rats (Wistar strain) exposed to sodium arsenite
  15. Hepatoprotective effect of Anacyclus pyrethrum Linn. against antitubercular drug-induced hepatotoxicity in SD rats
  16. Clinical Studies
  17. Effect of integrated Yoga and Physical therapy on audiovisual reaction time, anxiety and depression in patients with chronic multiple sclerosis: a pilot study
  18. Case Report
  19. A potential case of remission of Parkinson’s disease
Downloaded on 15.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jcim-2015-0105/html
Scroll to top button